Cargando…
Impact of DPYD, DPYS, and UPB1 gene variations on severe drug‐related toxicity in patients with cancer
Cancer treatment with a fluoropyrimidine (FP) is often accompanied by severe toxicity that may be dependent on the activity of catalytic enzymes encoded by the DPYD, DPYS, and UPB1 genes. Genotype‐guided dose individualization of FP therapy has been proposed in western countries, but our knowledge o...
Autores principales: | Yokoi, Katsuyuki, Nakajima, Yoko, Matsuoka, Hiroshi, Shinkai, Yasuko, Ishihara, Takuma, Maeda, Yasuhiro, Kato, Takema, Katsuno, Hidetoshi, Masumori, Koji, Kawada, Kenji, Yoshikawa, Tetsushi, Ito, Tetsuya, Kurahashi, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469832/ https://www.ncbi.nlm.nih.gov/pubmed/32619063 http://dx.doi.org/10.1111/cas.14553 |
Ejemplares similares
-
Clinical and genetic aspects of mild hypophosphatasia in Japanese patients
por: Yokoi, Katsuyuki, et al.
Publicado: (2019) -
Novel ARG1 variants identified in a patient with arginase 1 deficiency
por: Yokoi, Katsuyuki, et al.
Publicado: (2021) -
EOS at RO-03-UPB
por: Carabas, Mihai
Publicado: (2019) -
Maple syrup urine disease due to a paracentric inversion of chr 19 that disrupts
BCKDHA
: A case report
por: Yokoi, Katsuyuki, et al.
Publicado: (2022) -
Altered Pre-mRNA Splicing Caused by a Novel Intronic Mutation c.1443+5G>A in the Dihydropyrimidinase (DPYS) Gene
por: Nakajima, Yoko, et al.
Publicado: (2016)